Congenital Axonal Neuropathy with Encephalopathy

Congenital axonal neuropathy with encephalopathy is a very rare inherited nerve disease that starts at birth or very soon after birth. “Congenital” means present from birth. “Axonal neuropathy” means the long inner part of the nerve cell, called the axon, is damaged. “Encephalopathy” means the brain is also affected. In reported cases, babies often have low muscle tone, weak movement that is usually worse in the hands and feet, poor reflexes, feeding or breathing trouble, and later brain problems such as small head growth, seizures, and delayed development. It is usually described as an autosomal recessive disorder, which means a child usually inherits one changed gene copy from each parent.

Another names used for this condition include congenital axonal neuropathy and encephalopathy, congenital axonal neuropathy with encephalopathy, and in disease databases it is grouped under autosomal recessive axonal hereditary motor and sensory neuropathy. The published medical literature suggests that only a small number of cases have been described, so doctors still know much less about it than they know about common neuropathies.

Congenital axonal neuropathy with encephalopathy is a very rare inherited nerve and brain disease that usually starts at birth or soon after birth. The main problem is injury to the long nerve fibers called axons, together with brain involvement. Babies often have low muscle tone, weak arms and legs, poor reflexes, trouble swallowing, breathing problems, seizures, slow growth of the head, and severe delay in development. Published reports describe a high risk of aspiration pneumonia and breathing failure, so treatment is mainly careful supportive care from many specialists, not a single curative medicine. [GARD]

This disease does not currently have an FDA-approved cure that fixes the genetic problem. Because of that, doctors usually build treatment around the child’s main problems, such as seizures, poor feeding, excessive secretions, reflux, constipation, spasticity, pain, contractures, and respiratory weakness. Multidisciplinary care is the main evidence-based approach in related inherited axonal neuropathies and neurodevelopmental disorders. [GeneReviews]

Types

There is no widely accepted official subtype system for this exact rare disease in the major summaries I found. In practice, doctors usually describe it by the pattern of problems seen in the child rather than by fixed formal types.

1. Classic congenital form — symptoms begin at birth or soon after birth, with low muscle tone, distal weakness, poor reflexes, and early feeding or breathing problems.

2. Neuropathy-dominant form — the peripheral nerve weakness is very clear early, especially weakness in the limbs, with marked areflexia.

3. Brain-involvement form — the child has clear central nervous system features such as progressive microcephaly, seizures, and global developmental delay along with neuropathy.

4. Multisystem severe form — besides nerve and brain disease, some children may also have hearing problems, eye lesions, skeletal changes, genital findings such as cryptorchidism, and facial differences.

Causes

For this exact disease, the main proven cause is a disease-causing genetic change. Because the condition is so rare, the exact gene is not well established in the brief disease summaries, and many babies with very early axonal neuropathy remain without a precise molecular diagnosis even after testing. So the list below includes the known disease mechanism plus the important genetic causes doctors investigate when a baby shows this same clinical picture.

1. Autosomal recessive pathogenic variants. This is the main reported cause of the named disorder. In simple words, both copies of an important gene are changed, so nerves and the brain do not develop or work normally.

2. An unknown gene defect. In many infantile neuropathies, even modern testing does not always find the exact gene, so doctors may still suspect a hidden inherited mutation when the child’s signs fit the disorder well.

3. De novo genetic change. Some very early neuropathies can happen from a new mutation in the child even when neither parent is known to be affected. This is part of the broader genetic differential diagnosis in congenital neuropathy.

4. MPZ-related congenital neuropathy. MPZ gene changes are a recognized cause in the neonatal congenital neuropathy group and can produce severe weakness from birth. Doctors test for it because it can resemble congenital axonal disease early in life.

5. PMP22-related congenital neuropathy. PMP22 mutations are another known cause of severe early inherited neuropathy. It is checked because some newborns with marked hypotonia and weakness fall into this group.

6. EGR2-related neuropathy. EGR2 changes can cause very early severe neuropathy with major motor problems. It is part of the standard genetic search when infants present with congenital neuropathy.

7. NEFL-related neuropathy. NEFL mutations are linked with early neuropathy and may show major axonal involvement. This makes them an important cause to rule in or rule out.

8. MFN2-related axonal neuropathy. MFN2 is an important gene in axonal Charcot-Marie-Tooth disease and can present in infancy. It matters because MFN2 also connects neuropathy with mitochondrial problems.

9. GDAP1-related neuropathy. GDAP1 mutations are a known recessive cause of severe early neuropathy and can include breathing or vocal cord problems. Doctors often include this in the differential diagnosis.

10. PRX-related neuropathy. PRX mutations are another inherited cause of infantile neuropathy. They may cause severe sensory and motor nerve disease early in life.

11. MTMR2-related neuropathy. MTMR2 gene changes cause a recessive infantile neuropathy syndrome. This is checked when nerve biopsy or clinical findings suggest a hereditary neuropathy.

12. SBF2-related neuropathy. SBF2 mutations can cause severe childhood neuropathy and are part of the congenital or infantile inherited neuropathy gene list.

13. FGD4-related neuropathy. FGD4 is another recessive gene linked to infantile hereditary neuropathy. It becomes important when the child has delayed motor milestones, foot deformity, and areflexia.

14. SH3TC2-related neuropathy. SH3TC2 can produce early hereditary neuropathy with skeletal deformity and severe weakness, so it stays in the diagnostic list.

15. GAN-related giant axonal neuropathy. Giant axonal neuropathy is a separate disorder, but it can overlap clinically with congenital axonal neuropathy and can also involve the central nervous system.

16. PLA2G6-related infantile neuroaxonal dystrophy. This disorder can combine nerve and brain disease in infancy, so it is an important cause to consider when encephalopathy is prominent.

17. Mitochondrial disorders. The infantile axonal neuropathy review states that some mitochondrial diseases can cause early neuropathy with brain or systemic involvement. They are a major part of the cause search.

18. Spinal muscular atrophy and related non-5q SMA syndromes. These are not the same disease, but they can look very similar in a floppy weak newborn, so they are part of the real-world causal differential.

19. Hereditary motor and sensory neuropathy with corpus callosum problems. This is another rare inherited syndrome listed in reviews of infantile axonal neuropathies, especially when the brain is involved.

20. Rare acquired inflammatory neuropathy. The infantile neuropathy review says that acquired inflammatory causes are rare but can mimic inherited disease in children, so doctors sometimes test for them while working toward the final diagnosis.

Symptoms

1. Generalized hypotonia. This means the baby feels floppy. It is one of the earliest and most common reported signs and usually appears at birth or soon after birth.

2. Distal muscle weakness. Weakness is often stronger in the hands, forearms, feet, and lower legs because long nerves are affected first and most.

3. Diffuse areflexia. Deep tendon reflexes, such as the knee jerk, may be absent or very weak because the peripheral nerves do not carry signals normally.

4. Feeding difficulty. Weak sucking and swallowing can make feeding hard in newborns and infants. This may lead to poor growth and a need for tube feeding.

5. Swallowing difficulty. Trouble swallowing happens because the muscles involved in swallowing are weak or poorly coordinated. This also raises the risk of choking and aspiration.

6. Breathing difficulty. Some children have respiratory weakness from the start, and this is one reason the disease can become life-threatening early.

7. Progressive microcephaly. The head may become smaller than expected over time because the brain is also affected, not only the nerves outside the brain.

8. Seizures. Brain involvement can cause seizures. This is one of the key findings that separates this disease from a neuropathy that affects only the peripheral nerves.

9. Global developmental delay. The child may be late to smile, sit, speak, stand, or learn other milestones because both movement and brain development are impaired.

10. Hearing impairment. Some affected children have hearing loss or reduced hearing response, showing that the disease may involve more than one nerve system.

11. Eye lesions or eye problems. Eye findings have been reported as variable extra features. These are not present in every child, but they are part of the described spectrum.

12. Clubfoot or other foot deformity. Talipes equinovarus and toe abnormalities may appear because weak nerves and muscles affect limb posture and growth from early life.

13. Scoliosis or spinal curve. Abnormal muscle support around the spine can lead to a curved spine as the child grows.

14. Joint contractures. Some joints may become stiff and difficult to move because of long-standing muscle weakness and poor nerve supply.

15. Recurrent chest infection or aspiration pneumonia. This is often a later result of weak swallowing and breathing. It is a major reason for severe illness and poor outcome in reported cases.

Diagnostic tests

Doctors diagnose this disorder by combining the story from birth, the physical examination, nerve testing, brain testing, tissue studies, and genetic studies. The goal is not only to confirm neuropathy, but also to show that the problem is mainly axonal and that the brain is involved too.

1. Tone assessment. The doctor checks whether the baby is floppy or unusually stiff. In this disease, low tone is a very important early clue.
2. Muscle strength testing. The doctor looks for weakness, especially in the hands and feet. Even in babies, movement against gravity can be carefully observed.
3. Deep tendon reflex exam. Knee, ankle, and other reflexes are checked. Reduced or absent reflexes strongly support peripheral neuropathy.
4. Cranial nerve and swallowing exam. The doctor watches sucking, swallowing, facial movement, and breathing effort because bulbar weakness may be present.
5. Head circumference measurement. Repeated head size measurements help detect progressive microcephaly, which supports brain involvement.
6. Developmental milestone assessment. The care team checks head control, rolling, sitting, speech, and other milestones to measure global developmental delay.
7. Respiratory function bedside assessment. Doctors examine breathing pattern, chest movement, oxygen need, and signs of weak respiratory muscles because respiratory failure is a major risk.
8. Feeding and aspiration assessment. This may include direct feeding observation by trained staff to see poor suck, choking, or aspiration risk.
9. Hearing evaluation. Audiology testing is helpful when hearing impairment is suspected, because hearing problems are part of the variable clinical picture.
10. Genetic testing panel or exome sequencing. Genetic testing is one of the most important tests in infantile inherited neuropathies because many are genetic, although not all children get a precise answer.
11. Family testing and segregation study. Once a variant is found, parents may be tested to see whether the inheritance pattern fits an autosomal recessive disease.
12. Metabolic and mitochondrial blood tests. These tests help exclude other inherited diseases, especially mitochondrial disorders, that can produce early neuropathy with brain signs.
13. Nerve biopsy. A nerve biopsy can show whether the neuropathy is axonal and may reveal clues to a specific syndrome. In the classic report, sural nerve biopsy showed axonal atrophy and loss of large nerve fibers.
14. Muscle biopsy. In selected cases, muscle biopsy is added when doctors need more information about nerve-versus-muscle disease or a mitochondrial disorder.
15. Brain tissue pathology in exceptional cases. This is not a routine test, but published severe cases showed reduced brain microtubule-associated proteins and white-matter abnormalities on tissue study.
16. Nerve conduction studies. Nerve conduction studies measure how well electrical signals travel along nerves. They help show nerve damage and help separate axonal disease from demyelinating disease.
17. Needle electromyography. EMG checks how muscles respond to nerve signals. Together with nerve conduction studies, it helps confirm that weakness is coming from nerve disease rather than primary muscle disease
18. Brain MRI. Brain MRI is important when seizures, microcephaly, or developmental delay suggest encephalopathy. It may show structural or white-matter abnormalities and helps support central nervous system involvement.
19. Spine MRI or targeted neuroimaging. This is used when doctors need to exclude other structural causes of weakness or to study the broader nervous system.
20. Magnetic resonance neurography or nerve ultrasound in selected cases. These imaging tools are not always necessary, but they can help visualize peripheral nerves and assist in difficult neuropathy cases.

Non-pharmacological treatments

1. Respiratory physiotherapy helps clear mucus, improve chest movement, and lower the risk of lung infection. 2) Suctioning and airway clearance devices help when weak cough makes secretions hard to remove. 3) Noninvasive ventilation during sleep can support weak breathing muscles and improve oxygen and carbon dioxide control. 4) Careful swallow evaluation and feeding-position training can reduce choking and aspiration. These treatments do not cure the disease, but they protect the lungs, reduce emergencies, and improve comfort and survival.

2. Physical therapy helps maintain joint movement, support posture, reduce stiffness, and slow secondary contractures. 6) Stretching programs help keep muscles and tendons from becoming very tight. 7) Occupational therapy helps hand use, seating, daily care, and caregiver techniques. 8) Positioning devices, supportive chairs, and pressure-relief plans help children with severe weakness sit more safely and reduce skin injury. In inherited neuropathies, rehabilitation is used to preserve function and prevent complications from immobility.

3. Ankle-foot orthoses and braces can improve alignment, standing, and walking safety. 10) Customized footwear and inserts can reduce pressure points and improve balance. 11) Serial casting or splinting may help selected contractures. 12) Mobility aids such as walkers, strollers, or wheelchairs reduce falls and save energy. These methods work by improving body mechanics and reducing the extra effort weak muscles must make.

4. Speech and language therapy supports communication and also helps oral-motor function. 14) Feeding therapy teaches safer textures, pacing, and caregiver handling. 15) Nutrition assessment helps prevent weight loss, dehydration, and vitamin deficiency. 16) Ketogenic diet may be considered only in carefully selected children with drug-resistant epilepsy under specialist supervision, because it can reduce seizures in some developmental and epileptic encephalopathies but needs close monitoring.

5. Hearing support, eye care, and vision correction are important because some patients have hearing or eye problems. 18) Orthopedic follow-up helps detect scoliosis, hip problems, and foot deformities early. 19) Developmental therapy and special education help families build communication and daily-life skills even when progress is slow. 20) Genetic counseling helps parents understand recurrence risk, family testing, and future pregnancy choices. These steps improve safety, planning, and long-term quality of life.

Drug treatments

There is no drug approved by the FDA specifically for congenital axonal neuropathy with encephalopathy itself, so medicines are chosen for symptoms. 1) Levetiracetam is an antiseizure drug often used when seizures occur; usual label-based dosing is started in divided doses and adjusted by age and weight, usually twice daily; it works mainly by binding synaptic vesicle protein SV2A and may cause sleepiness, irritability, and dizziness. 2) Valproic acid / valproate is another antiseizure drug that increases brain inhibitory signaling and is used for some generalized seizures, but it can cause liver injury, pancreatitis, and major fetal harm, so it needs great caution. [FDA labels]

3. Clobazam is a benzodiazepine used for difficult seizures; it is usually given once or twice daily depending on the plan, and it works by enhancing GABA activity in the brain; common problems are sedation, drooling, constipation, and breathing suppression, especially with other sedatives. 4) Diazepam rectal gel is often kept as a rescue medicine for seizure clusters; it is not for daily disease control but for emergencies, and the FDA label stresses caregiver training because it can cause heavy sleepiness and respiratory depression.

4. Topiramate is a broad antiseizure drug used in some children with persistent seizures; dose is slowly increased over time, often twice daily, and it works through several pathways including sodium-channel effects and enhancement of GABA; side effects can include sleepiness, poor appetite, metabolic acidosis, and trouble with concentration. 6) Lamotrigine is another antiseizure medicine used when the seizure pattern fits; it must be increased slowly because of the risk of serious rash, especially with valproate.

5. Lacosamide may be used for focal seizures in older patients; it is usually given twice daily and works partly by enhancing slow inactivation of sodium channels; dizziness, double vision, and heart conduction changes can happen. 8) Clonazepam may help myoclonic or mixed seizure patterns, but it can also cause sedation, drooling, tolerance, and withdrawal problems if stopped quickly.

6. Gabapentin may be considered if the child has neuropathic pain or selected seizure needs; it is usually given in divided doses and can cause sleepiness and dizziness. 10) Baclofen is not for the genetic disease itself, but it can reduce spasticity and painful muscle tightness; it is usually given several times daily or by intrathecal pump in special cases, and abrupt withdrawal can be dangerous.

7. Glycopyrrolate may help troublesome drooling and thick secretions in children with poor swallowing; it works by blocking muscarinic receptors and reducing saliva production, but it can worsen constipation, urinary retention, and overheating. 12) Omeprazole may help reflux, esophagitis, and feed-related discomfort when swallowing is weak; it lowers stomach acid, but long-term use can carry risks such as low magnesium or infections in some patients.

8. Polyethylene glycol 3350 may be used for constipation caused by immobility, low fluid intake, or anticholinergic drugs; it draws water into stool and makes bowel movements easier. 14) Albuterol may help wheeze or airway reactivity during respiratory illness, though it does not treat respiratory muscle weakness itself; it relaxes airway smooth muscle and may cause tremor or fast heart rate.

9. OnabotulinumtoxinA may be used in selected patients with focal spasticity; it weakens overactive muscles by blocking acetylcholine release, but spread of toxin effect can be dangerous, especially in medically fragile children. 16) Trihexyphenidyl is sometimes used for dystonia or abnormal movements in neurologic disease; it is anticholinergic, so dry mouth, constipation, and confusion can occur.

10. Melatonin is sometimes used for sleep problems, though it is a supplement rather than a classic prescription drug. 18) Acetaminophen may help pain or fever during infections. 19) Antibiotics are used promptly when aspiration pneumonia or chest infection is suspected, but the exact drug depends on the infection. 20) Vitamin D plus calcium support may be prescribed when immobility raises bone-risk concerns. These last treatments are supportive and individualized, not disease-specific cures.

Dietary molecular supplements

1. Vitamin D may support bone strength in children with low mobility.

2. Calcium may support bones when intake is low.

3. Iron is used only when iron deficiency is proven.

4. Vitamin B12 may support nerve and blood health if deficient.

5. Folate is useful when intake is poor or deficiency exists. These supplements help the body work better when a real deficiency is present, but they do not correct the underlying gene problem.

6. Omega-3 fatty acids may support overall nutrition, though proof for this rare disease is limited.

7. Coenzyme Q10 is sometimes tried in neurologic practice, but evidence for this condition is weak.

8. L-carnitine may be considered in selected metabolic contexts or valproate-related deficiency risk.

9. Magnesium may be useful if low levels, constipation, or cramps are issues.

10. Protein-rich medical nutrition formulas may help growth when oral intake is poor. Use of these products should be guided by a pediatric neurologist and dietitian because the main evidence-based role is nutritional support, not cure.

Immunity, regenerative, or stem-cell drug approaches

At present, there is no FDA-approved immunity booster, regenerative drug, or stem-cell drug proven to treat congenital axonal neuropathy with encephalopathy. That is the most important fact for families. Research in inherited neuropathies is moving toward gene therapy, nucleic-acid therapy, enzyme-based therapy in selected disorders, and cell-based repair, but these are disease-specific and mostly experimental.

Examples of approaches discussed in the wider inherited-neuropathy field are 1) viral vector gene therapy, 2) antisense or RNA-based therapy, 3) small-molecule disease modifiers, 4) enzyme replacement for other rare neuropathies, 5) mesenchymal stem-cell research, and 6) neurotrophic-factor or regenerative signaling strategies. These should be viewed as research directions, not standard treatment for this disorder. Families should be very careful with clinics selling “stem cell cures” without strong published evidence.

Surgeries or procedures

1. Gastrostomy tube placement may be done when swallowing is unsafe or nutrition is failing.

2. Tracheostomy may be needed in severe long-term airway or ventilation failure.

3. Orthopedic foot or tendon surgery may be used for major deformity that bracing cannot control.

4. Spinal surgery may be considered for severe scoliosis affecting comfort or breathing.

5. Hip stabilization or contracture-release procedures may be needed in selected children with painful deformity or dislocation. These procedures do not cure the disease; they are done to improve safety, feeding, breathing, posture, or comfort.

Preventions

There is no way to completely prevent the disease after conception if the causative mutation is present, but many complications can be prevented. Important prevention steps are aspiration prevention, vaccination, rapid treatment of chest infection, safe sleep and breathing monitoring, regular swallow review, nutrition review, stretching and contracture prevention, skin care and pressure prevention, brace fitting and fall prevention, and genetic counseling before future pregnancy. These steps target the main causes of harm such as aspiration, respiratory failure, malnutrition, and deformity.

When to see doctors

A child with this condition needs regular care from pediatric neurology, rehabilitation, nutrition, pulmonology, gastroenterology, orthopedics, and genetics. Urgent medical review is needed for breathing difficulty, blue color, repeated choking, dehydration, new or longer seizures, fever with cough, reduced feeding, unusual sleepiness, new weakness, or pain from contractures or hip/spine problems. Because outcome can worsen with aspiration pneumonia or respiratory insufficiency, families should not wait when breathing or feeding changes suddenly.

What to eat and what to avoid

Best food choices are usually soft or texture-modified foods recommended by a swallow team, thickened liquids when advised, calorie-dense meals for poor growth, enough protein, enough fluids, fruits and fiber for bowel health, and medically supervised formulas when oral intake is poor. Children with refractory seizures may sometimes be offered a ketogenic diet, but only under specialist supervision because it has risks and requires exact monitoring.

Foods or situations to avoid include thin liquids if the child aspirates them, rushed feeding, lying flat during feeds, very dry or crumbly foods that are hard to swallow, foods that trigger reflux, severe constipation from low-fiber patterns, dehydration, unmonitored supplement use, and “miracle cure” diets. The correct diet depends more on swallow safety and growth than on a special disease-specific food.

FAQs

What is this disease? It is a rare genetic disorder that damages peripheral axons and also affects the brain. Is it present at birth? Usually yes, or it appears very soon after birth. Is it inherited? Reported classic cases are often autosomal recessive, while some overlapping axonal-neuropathy encephalopathy syndromes can arise from other genes and inheritance patterns. Is there a cure? No FDA-approved cure is available now. Can treatment still help? Yes, supportive treatment can greatly reduce complications and improve comfort.

Do all children have seizures? Not all, but seizures are a recognized major feature. Why are swallowing problems so serious? Because choking and aspiration can lead to pneumonia. Why are breathing problems common? Because weak muscles and brain involvement can impair airway protection and ventilation. Can therapy really help if the disease is genetic? Yes, therapy cannot remove the mutation, but it can preserve function and reduce secondary damage. Are braces and seating devices worth it? Yes, they often improve posture, safety, and energy use.

Are vitamins enough to treat it? No, vitamins only help when nutrition is poor or deficiency is present. Should families try stem-cell clinics? Not without strong evidence and specialist advice; there is no proven stem-cell cure for this disease. Can surgery cure the weakness? No, surgery only helps selected complications such as feeding failure or deformity. What is the biggest day-to-day goal? Prevent aspiration, breathing failure, malnutrition, pain, and contractures. What is the most important long-term step for families? Build a regular multidisciplinary follow-up plan and seek urgent care early when breathing, feeding, or seizures worsen.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 10, 2025.